Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
Clinical trial NCT06660810 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06660810
- Sponsor
- John Rieth
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2026-05-26
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.